Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 16 2023 - 8:00AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of May 2023
Commission file number: 001-39674
G MEDICAL INNOVATIONS HOLDINGS LTD.
(Translation of registrant’s name into English)
5 Oppenheimer St.
Rehovot 7670105, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
CONTENTS
On May 15, 2023, G Medical
Innovations Holdings Ltd. (the “Company”) issued a press release titled “G Medical Innovations Holdings Ltd. Announces
Receipt of Nasdaq Hearings Panel’s Decision to Grant Exception for Continued Listing.” A copy of this press release is
furnished herewith as Exhibit 99.1.
The press release included
as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company’s Registration
Statement on Form F-3 (File No. 333-266090) and on Form S-8 (File No. 333-266063), filed with the SEC, to be a part thereof from the
date on which this Report is submitted to the extent not superseded by documents or reports subsequently filed or furnished.
EXHIBITS
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
| |
G Medical Innovations Holdings Ltd. |
| |
|
|
| Date: May 16, 2023 |
By: |
/s/ Yacov Geva |
| |
|
Name: |
Yacov Geva |
| |
|
Title: |
Chief Executive Officer |
3
G Medical Innovations (NASDAQ:GMVD)
Historical Stock Chart
From Nov 2024 to Dec 2024
G Medical Innovations (NASDAQ:GMVD)
Historical Stock Chart
From Dec 2023 to Dec 2024
